Top Markets
Coin of the day
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Rang in Aktien #33504
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Aktienkurs
$1.12
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$7.52M
Veränderung (1 Tag)
4.51%
Veränderung (1 Jahr)
-94.79%
Land
US
Handel NeoImmuneTech, Inc. (950220)

Kategorie

Kursverlauf für NeoImmuneTech, Inc. (950220)
Höchster Schlusskurs: $1.08 am 2026-08-01

Niedrigster Schlusskurs: $301.12 am 2021-03-01
Kursverlauf der Aktie von NeoImmuneTech, Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -22.30%
2025 -38.71%
2024 -40.13%
2023 -56.86%
2022 -64.86%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.95 6.51%
CH
$1.07K -6.40%
KR
$254.79 13.07%
BE